Status:

UNKNOWN

Pulmonary Rehabilitation to Improve Physical Capacity After Pulmonary Embolism

Lead Sponsor:

Ostfold Hospital Trust

Collaborating Sponsors:

University Hospital, Akershus

Ullevaal University Hospital

Conditions:

Pulmonary Embolism

Eligibility:

All Genders

18-75 years

Phase:

NA

Brief Summary

This project aims to evaluate a rehabilitation program as treatment and uncover potential pathophysiological mechanisms of a newly identified chronic condition named "Post Pulmonary Embolism Syndrome"...

Detailed Description

The newly identified Post Pulmonary Embolism Syndrome (PPS) is characterized by chronic persistent, but unexplained dyspnea (i.e. without signs of pulmonary hypertension or pulmonary abnormality). Sym...

Eligibility Criteria

Inclusion

  • Objectively diagnosed symptomatic pulmonary embolism by CTPA or high-probability scintigraphy 6 months to 6 years before inclusion
  • Persistent dyspnea defined as modified Medical Research Council (mMRC) breathlessness scale \>= 1 that has appeared or worsened after the diagnosis of PE (eligibility criteria for randomization)

Exclusion

  • Significant pulmonary disease (COPD GOLD \>= 2, restrictive pulmonary disease, lung cancer or pleural disease.
  • Heart failure (either HFrEF, HFmrEF or HFpEF as defined in ESC guidelines)
  • Significant valvular heart disease
  • Chronic thromboemboli pulmonary hypertension (CTEPH)
  • Patients unfit for rehabilitation or walking tests du to old age, physical disability or disease
  • Patients with a history of poor compliance or any condition that would interfere with the ability to comply with the study protocol e.g. history of drug abuse, excessive alcohol beverage consumption, cognitive dysfunction or severe psychiatric disease
  • Active malignancy
  • Life expectancy less than 3 months
  • Pregnancy

Key Trial Info

Start Date :

January 20 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 30 2024

Estimated Enrollment :

209 Patients enrolled

Trial Details

Trial ID

NCT03405480

Start Date

January 20 2018

End Date

March 30 2024

Last Update

November 3 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

The hospital of Østfold, Kalnes

Grålum, Norway, 1714